{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:55:26Z","timestamp":1789188926525,"version":"build-2803163510"},"reference-count":96,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.pain.2009.05.017","type":"journal-article","created":{"date-parts":[[2009,8,27]],"date-time":"2009-08-27T10:10:38Z","timestamp":1251367838000},"page":"18-25","source":"Crossref","is-referenced-by-count":145,"title":["Reduction of allodynia in patients with complex regional pain syndrome: A double-blind placebo-controlled trial of topical ketamine"],"prefix":"10.1097","volume":"146","author":[{"given":"Philip M.","family":"Finch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lone","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210112","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1476-5381.1983.tb11031.x","article-title":"The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate.","volume":"79","author":"Anis","year":"1983","journal-title":"Br J Pharmacol"},{"key":"R2-9-20210112","first-page":"63","article-title":"The effect of N-methyl-d-aspartate antagonist (ketamine) on single and repeated nociceptive stimuli: a placebo-controlled experimental human study.","volume":"81","author":"Arendt-Nielsen","year":"1996","journal-title":"Anesth Analg"},{"key":"R3-9-20210112","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0304-3959(94)90149-X","article-title":"Response of chronic neuropathic pain syndromes to ketamine: a preliminary study.","volume":"56","author":"Backonja","year":"1994","journal-title":"Pain"},{"key":"R4-9-20210112","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pain.2008.12.003","article-title":"Ketamine for chronic non-cancer pain.","volume":"141","author":"Bell","year":"2009","journal-title":"Pain"},{"key":"R5-9-20210112","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/bja\/43.5.496","article-title":"Alteration in response to somatic pain associated with anaesthesia: XX: Ketamine.","volume":"43","author":"Bovill","year":"1971","journal-title":"Br J Anaesth"},{"key":"R6-9-20210112","first-page":"169","article-title":"Evidence for the interaction of glutamate and NK1 receptors in the periphery.","volume":"160-","author":"Carlton","year":"1998","journal-title":"Brain Res"},{"key":"R7-9-20210112","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.2174\/1381612054865082","article-title":"NMDA antagonists and neuropathic pain: multiple drug targets and multiple uses.","volume":"23","author":"Chizh","year":"2005","journal-title":"Curr Pharm Des"},{"key":"R8-9-20210112","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2165\/00044011-200929050-00004","article-title":"Development of a sublingualoral formulation of ketamine for use in neuropathic pain: preliminary findings from a three-way randomized crossover study.","volume":"29","author":"Chong","year":"2009","journal-title":"Clin Drug Investig"},{"key":"R9-9-20210112","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/jps.2600710516","article-title":"Bioavailability, pharmokinetics, and analgesic activity of ketamine in humans.","volume":"71","author":"Clements","year":"1982","journal-title":"J Pharm Sci"},{"key":"R10-9-20210112","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0165-0173(97)00010-6","article-title":"Receptor localization in the mammalian dorsal horn and primary afferent neurons.","volume":"24","author":"Coggeshall","year":"1997","journal-title":"Brain Res Rev"},{"key":"R11-9-20210112","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1526-4637.2004.04043.x","article-title":"Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome.","volume":"5","author":"Correll","year":"2004","journal-title":"Pain Med"},{"key":"R12-9-20210112","first-page":"122","article-title":"Clinical application of ketamine ointment in the treatment of sympathetically maintained pain.","volume":"2","author":"Crowley","year":"1998","journal-title":"Int J Pharm Compd"},{"key":"R13-9-20210112","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijpharm.2004.07.038","article-title":"In vitro and in vivo percutaneous absorption of topical dosage forms: case studies.","volume":"291","author":"Csoka","year":"2005","journal-title":"Int J Pharm"},{"key":"R14-9-20210112","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1360-0443.2001.96574910.x","article-title":"In and out of the K-hole: a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users.","volume":"96","author":"Curran","year":"2001","journal-title":"Addiction"},{"key":"R15-9-20210112","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1526-4637.2007.00314.x","article-title":"Side effects of ketamine in the long-term treatment of neuropathic pain.","volume":"9","author":"Cvrcek","year":"2008","journal-title":"Pain Med"},{"key":"R16-9-20210112","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jpainsymman.2006.11.004","article-title":"Multimodal approaches to the management of neuropathic pain: the role of topical analgesia.","volume":"33","year":"2007","journal-title":"J Pain Symptom Manage"},{"key":"R17-9-20210112","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.pain.2004.07.020","article-title":"Topical clonidine antinociception.","volume":"111","author":"Dogrul","year":"2004","journal-title":"Pain"},{"key":"R18-9-20210112","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/cpt196563279","article-title":"Pharmacologic effects of CI-581, a new dissociative anesthetic, in man.","volume":"6","author":"Domino","year":"1965","journal-title":"Clin Pharmacol Ther"},{"key":"R19-9-20210112","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/bja\/aen107","article-title":"Neuropathic pain: emerging treatments.","volume":"101","author":"Dray","year":"2008","journal-title":"Br J Anaesth"},{"key":"R20-9-20210112","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000211408","article-title":"Human skin irritation studies of a lecithin microemulsion gel and of lecithin liposomes.","volume":"9","author":"Dreher","year":"1996","journal-title":"Skin Pharmacol"},{"key":"R21-9-20210112","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pain.2006.02.013","article-title":"Sensory changes in the forehead of patients with complex regional pain syndrome.","volume":"123","author":"Drummond","year":"2006","journal-title":"Pain"},{"key":"R22-9-20210112","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1212\/WNL.57.7.1296","article-title":"Pain increases during sympathetic arousal in patients with complex regional pain syndrome.","volume":"57","author":"Drummond","year":"2001","journal-title":"Neurology"},{"key":"R23-9-20210112","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0306-4522(03)00009-5","article-title":"N-methyl-d-aspartate-induced excitation and sensitization of normal and inflamed nociceptors.","volume":"118","author":"Du","year":"2003","journal-title":"Neuroscience"},{"key":"R24-9-20210112","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-2999(97)01116-3","article-title":"Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord.","volume":"333","author":"Ebert","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"R25-9-20210112","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0304-3959(94)90129-5","article-title":"Relief of post-herpetic neuralgia with the N-methyl-d-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo.","volume":"58","author":"Eide","year":"1994","journal-title":"Pain"},{"key":"R26-9-20210112","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00006123-199708000-00043","article-title":"Relief of glossopharyngeal neuralgia by ketamine-induced N-methyl-aspartate receptor blockade.","volume":"41","author":"Eide","year":"1997","journal-title":"Neurosurgery"},{"key":"R27-9-20210112","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0304-3959(94)00182-E","article-title":"Continuous subcutaneous administration of the N-methyl-d-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia.","volume":"61","author":"Eide","year":"1995","journal-title":"Pain"},{"key":"R28-9-20210112","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1227\/00006123-199512000-00007","article-title":"Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-d-aspartate receptor activation.","volume":"37","author":"Eide","year":"1995","journal-title":"Neurosurgery"},{"key":"R29-9-20210112","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0304-3959(95)00113-1","article-title":"NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride.","volume":"64","author":"Felsby","year":"1995","journal-title":"Pain"},{"key":"R30-9-20210112","first-page":"36","article-title":"An evidence-based algorithm for the treatment of neuropathic pain.","volume":"9","author":"Finnerup","year":"2007","journal-title":"MedGenMed"},{"key":"R31-9-20210112","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0885-3924(99)00018-4","article-title":"Analgesic effect of oral ketamine in chronic neuropathic pain of spinal origin: a case report.","volume":"18","author":"Fisher","year":"1999","journal-title":"J Pain Symptom Manage"},{"key":"R32-9-20210112","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1526-4637.2000.00006.x","article-title":"Topical ketamine gel: possible role in treating neuropathic pain.","volume":"1","author":"Gammaitoni","year":"2000","journal-title":"Pain Med"},{"key":"R33-9-20210112","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1503\/cmaj.060146","article-title":"Neuropathic pain: a practical guide for the clinician.","volume":"175","author":"Gilron","year":"2006","journal-title":"CMAJ"},{"key":"R34-9-20210112","doi-asserted-by":"crossref","first-page":"175","DOI":"10.36076\/ppj.2005\/8\/175","article-title":"Multi-day low dose ketamine infusion for the treatment of complex regional pain syndrome.","volume":"8","author":"Goldberg","year":"2005","journal-title":"Pain Physician"},{"key":"R35-9-20210112","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/bja\/53.8.805","article-title":"Pharmacokinetics and analgesic effects of i.m. and oral ketamine.","volume":"53","author":"Grant","year":"1981","journal-title":"Br J Anaesth"},{"key":"R36-9-20210112","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/AJP.0b013e318156db3b","article-title":"Vasodilative effect of isosorbide dinitrate ointment in complex regional pain syndrome type 1.","volume":"24","author":"Groeneweg","year":"2008","journal-title":"Clin J Pain"},{"key":"R37-9-20210112","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1526-4637.2002.02029.x","article-title":"Successful treatment of a nine-year case of complex regional pain syndrome type-I (reflex sympathetic dystrophy) with intravenous ketamine-infusion therapy in a warfarin-anticoagulated adult female patient.","volume":"3","author":"Harbut","year":"2002","journal-title":"Pain Med"},{"key":"R38-9-20210112","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0304-3959(99)00104-9","article-title":"Complex regional pain syndrome: are the IASP diagnostic criteria valid and sufficiently comprehensive?","volume":"83","author":"Harden","year":"1999","journal-title":"Pain"},{"key":"R39-9-20210112","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.tripleo.2007.09.030","article-title":"Use of topical medication in orofacial neuropathic pain: a retrospective study.","volume":"105","author":"Heir","year":"2008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"R40-9-20210112","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1371\/journal.pmed.0020164","article-title":"Analgesic therapy in postherpetic neuralgia: a quantitative systematic review.","volume":"2","author":"Hempenstall","year":"2005","journal-title":"PLoS Med"},{"key":"R41-9-20210112","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/AJP.0b013e318156db26","article-title":"Topical amitriptyline versus lidocaine in the treatment of neuropathic pain.","volume":"24","author":"Ho","year":"2008","journal-title":"Clin J Pain"},{"key":"R42-9-20210112","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1213\/01.ANE.0000086618.28845.9B","article-title":"Ketamine in chronic pain management: an evidence-based review.","volume":"97","author":"Hocking","year":"2003","journal-title":"Anesth Analg"},{"key":"R44-9-20210112","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0014-2999(95)00449-U","article-title":"Glutamate participates in the peripheral modulation of thermal hyperalgesia in rats.","volume":"284","author":"Jackson","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"R45-9-20210112","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuroscience.2004.06.040","article-title":"Peripheral glutamate receptors contribute to mechanical hyperalgesia in a neuropathic pain model of the rat.","volume":"128","author":"Jang","year":"2004","journal-title":"Neuroscience"},{"key":"R46-9-20210112","first-page":"180","article-title":"The history of pluronic lecithin organogel.","volume":"7","author":"Jones","year":"2003","journal-title":"Int J Pharm Compd"},{"key":"R47-9-20210112","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2478\/v10007-007-0016-6","article-title":"Topical dosage form of valdecoxib: preparation and pharmcological evaluation.","volume":"57","author":"Kesavanarayanan","year":"2007","journal-title":"Acta Pharm"},{"key":"R48-9-20210112","first-page":"14","article-title":"Topical lidocaine for the treatment of postherpetic neuralgia.","volume":"1-","author":"Khaliq","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"R49-9-20210112","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1533-2500.2007.00123.x","article-title":"Complete recovery from intractable complex regional pain syndrome, CRPS-type I, following anesthetic ketamine and midazolam.","volume":"7","author":"Kiefer","year":"2007","journal-title":"Pain Pract"},{"key":"R50-9-20210112","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1526-4637.2007.00402.x","article-title":"Efficacy of ketamine in anesthetic dosage for the treatment of refractory complex regional pain syndrome: an open-label phase II study.","volume":"9","author":"Kiefer","year":"2007","journal-title":"Pain Med"},{"key":"R51-9-20210112","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1526-4637.2006.00223.x","article-title":"A pilot open-label study of the efficacy of subanesthetic isomeric S()-ketamine in refractory CRPS patients.","volume":"9","author":"Kiefer","year":"2008","journal-title":"Pain Med"},{"key":"R52-9-20210112","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3940(00)00944-7","article-title":"Localization of ionotropic glutamate receptors in peripheral axons of human skin.","volume":"283","author":"Kinkelin","year":"2000","journal-title":"Neurosci Lett"},{"key":"R53-9-20210112","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/AJP.0b013e318158ed9e","article-title":"Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival?","volume":"24","author":"Knotkova","year":"2008","journal-title":"Clin J Pain"},{"key":"R54-9-20210112","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.acn.2007.05.005","article-title":"The neurocognitive effects of 5 day anesthetic ketamine for the treatment of refractory complex regional pain syndrome.","volume":"22","author":"Koffler","year":"2007","journal-title":"Arch Clin Neuropsychol"},{"key":"R55-9-20210112","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0304-3959(92)90262-A","article-title":"Dynamic and static components of mechanical hyperalgesia in human hairy skin.","volume":"51","author":"Koltzenburg","year":"1992","journal-title":"Pain"},{"key":"R56-9-20210112","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/brain\/117.3.579","article-title":"Nociceptor modulated central sensitization causes mechanical hyperalgesia in acute chemogenic and chronic neuropathic pain.","volume":"117","author":"Koltzenburg","year":"1994","journal-title":"Brain"},{"key":"R57-9-20210112","first-page":"27","article-title":"Ketamine as an analgesic: parental, oral, rectal, subcutaneous, transdermal and intranasal administration.","volume":"16","author":"Kronenberg","year":"2002","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"R58-9-20210112","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1093\/brain\/awn123","article-title":"fMRI reveals distinct CNS processing during symptomatic and recovered complex regional pain syndrome in children.","volume":"131","author":"Lebel","year":"2008","journal-title":"Brain"},{"key":"R59-9-20210112","first-page":"320","article-title":"CH H, Huang H, Tsai M, CJ L, Sun W. Analgesic effect of lidocaine patch 5 in the treatment of acute herpes zoster: a double-blind and vehicle-controlled study.","volume":"33","author":"Lin","year":"2008","journal-title":"Reg Anesth Pain Med"},{"key":"R60-9-20210112","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/00000542-200507000-00021","article-title":"Topical 2 amitriptyline and 1 ketamine in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial.","volume":"103","author":"Lynch","year":"2005","journal-title":"Anesthesiology"},{"key":"R61-9-20210112","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jpain.2005.04.008","article-title":"Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study.","volume":"6","author":"Lynch","year":"2005","journal-title":"J Pain"},{"key":"R62-9-20210112","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.pain.2004.12.001","article-title":"Brain processing during mechanical hyperalgesia in complex regional pain syndrome: a functional MRI study.","volume":"114","author":"Maihofner","year":"2005","journal-title":"Pain"},{"key":"R63-9-20210112","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1212\/01.wnl.0000200961.49114.39","article-title":"Functional imaging of allodynia in complex regional pain syndrome.","volume":"66","author":"Maihofner","year":"2006","journal-title":"Neurology"},{"key":"R64-9-20210112","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0304-3959(00)00332-8","article-title":"Patterns of spread in complex regional pain syndrome, type I (reflex sympathetic dystrophy).","volume":"88","author":"Maleki","year":"2000","journal-title":"Pain"},{"key":"R65-9-20210112","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00002826-199508000-00008","article-title":"Intravenous infusion of the NMDA antagonist, ketamine, in chronic posttraumatic pain with allodynia: a double-blind comparison to alfentanil and placebo.","volume":"18","author":"Max","year":"1995","journal-title":"Clin Neuropharmacol"},{"key":"R66-9-20210112","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/rheumatology\/keg298","article-title":"Referred sensations in patients with complex regional pain syndrome type 1.","volume":"42","author":"McCabe","year":"2003","journal-title":"Rheumatology"},{"key":"R67-9-20210112","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/0885-3924(95)00102-5","article-title":"Long-term ketamine subcutaneous infusion in neuropathic cancer pain.","volume":"10","author":"Mercadante","year":"1995","journal-title":"J Pain Symptom Manage"},{"key":"R68-9-20210112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(98)00048-3","article-title":"The induction of pain: an integrative review.","volume":"57","author":"Millan","year":"1999","journal-title":"Prog Neurobiol"},{"key":"R69-9-20210112","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0304-3959(96)03080-1","article-title":"The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral input.","volume":"67","author":"Nikolajsen","year":"1996","journal-title":"Pain"},{"key":"R70-9-20210112","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF03005598","article-title":"Continuous subcutaneous injection of ketamine for cancer pain.","volume":"37","author":"Oshima","year":"1990","journal-title":"Can J Anaesth"},{"key":"R71-9-20210112","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0304-3959(94)00139-6","article-title":"Beneficial effects of ketamine in a chronic pain state with allodynia, possibly due to central sensitization.","volume":"60","author":"Persson","year":"1995","journal-title":"Pain"},{"key":"R72-9-20210112","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.neuroimage.2006.03.045","article-title":"Patterns of cortical reorganization parallel impaired tactile discrimination and pain intensity in complex regional pain syndrome.","volume":"32","author":"Pleger","year":"2006","journal-title":"NeuroImage"},{"key":"R73-9-20210112","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/01.ajp.0000149800.39240.95","article-title":"Topically administered ketamine reduces capsaicin-evoked mechanical hyperalgesia.","volume":"22","author":"Poyhia","year":"2006","journal-title":"Clin J Pain"},{"key":"R74-9-20210112","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1212\/01.WNL.0000055848.00032.39","article-title":"Topical ketamine treatment of postherpetic neuralgia.","volume":"60","author":"Quan","year":"2003","journal-title":"Neurology"},{"key":"R75-9-20210112","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/eujp.2001.0232","article-title":"Interindividual differences in the analgesic response to ketamine in chronic orofacial pain.","volume":"5","author":"Rabben","year":"2001","journal-title":"Eur J Pain"},{"key":"R76-9-20210112","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0304-3959(98)00202-4","article-title":"Hemisensory impairment in patients with complex regional pain syndrome.","volume":"80","author":"Rommel","year":"1999","journal-title":"Pain"},{"key":"R77-9-20210112","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0304-3959(01)00332-3","article-title":"Quantitative sensory testing, neurophysiological and psychological examination in patients with complex regional pain syndrome and hemisensory deficits.","volume":"93","author":"Rommel","year":"2001","journal-title":"Pain"},{"key":"R78-9-20210112","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.2174\/1381612054865019","article-title":"Topical analgesics in neuropathic pain.","volume":"11","author":"Sawynok","year":"2005","journal-title":"Curr Pharm Des"},{"key":"R79-9-20210112","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2474-9-15","article-title":"Analgesic effect of percutaneously absorbed non-steroidal anti-inflammatory drugs: an experimental study in a rat acute inflammation model.","volume":"9","author":"Sekiguchi","year":"2008","journal-title":"BMC Musculoskelet Disord"},{"key":"R80-9-20210112","first-page":"339","article-title":"Ketamine treatment for intractable pain in a patient with severe refractory complex regional pain syndrome: a case report.","volume":"11","author":"Shirani","year":"2008","journal-title":"Pain Physician"},{"key":"R81-9-20210112","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1046\/j.1526-4637.2003.03032.x","article-title":"Topical ketamine in the treatment of mucositis pain.","volume":"4","author":"Slatkin","year":"2003","journal-title":"Pain Med"},{"key":"R82-9-20210112","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0304-3959(93)90214-A","article-title":"Ketamine hydrochloride in the treatment of phantom limb pain.","volume":"54","author":"Stannard","year":"1993","journal-title":"Pain"},{"key":"R83-9-20210112","first-page":"22","article-title":"Ketamine as an adjuvant in sympathetic blocks for management of central sensitization following peripheral nerve injury.","volume":"3","author":"Sunder","year":"2008","journal-title":"J Brachial Plex Peripher Nerve Inj"},{"key":"R84-9-20210112","first-page":"99","article-title":"Percutaneous dermal drug delivery for local pain control.","volume":"2","author":"Tadicherla","year":"2006","journal-title":"Ther Clin Risk Manag"},{"key":"R85-9-20210112","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0304-3959(97)00189-9","article-title":"The NMDA-receptor antagonist ketamine abolishes neuropathic pain after epidural administration in a clinical case.","volume":"75","author":"Takahashi","year":"1998","journal-title":"Pain"},{"key":"R86-9-20210112","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/bja\/aem398","article-title":"Inflammation-induced up-regulation of ionotropic glutamate receptor expression in human skin.","volume":"100","author":"Tan","year":"2008","journal-title":"Br J Anaesth"},{"key":"R87-9-20210112","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00002508-199809000-00013","article-title":"Central nervous system abnormalities in complex regional pain syndrome (CRPS): clinical and quantitative evidence of medullary dysfunction.","volume":"14","author":"Thimineur","year":"1998","journal-title":"Clin J Pain"},{"key":"R88-9-20210112","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0031-6865(99)00053-9","article-title":"Excitatory amino acid agonists and antagonists: pharmacology and therapeutic applications.","volume":"74","author":"Trist","year":"2000","journal-title":"Pharm Acta Helv"},{"key":"R89-9-20210112","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.jpainsymman.2008.02.004","article-title":"The use of topical opioids for systemic pain management.","volume":"36","author":"Turris","year":"2008","journal-title":"J Pain Symptom Manage"},{"key":"R90-9-20210112","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1053\/rapm.2002.35517","article-title":"Analgesic effects of ketamine ointment in patients with complex regional pain syndrome Type 1.","volume":"27","author":"Ushida","year":"2002","journal-title":"Reg Anesth Pain Med"},{"key":"R91-9-20210112","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0304-3959(00)00488-7","article-title":"Treatment of post-stroke pain with oral ketamine.","volume":"92","author":"Vick","year":"2001","journal-title":"Pain"},{"key":"R92-9-20210112","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/0091270002042001008","article-title":"Concentration-effect relationships for intravenous alfentanil and ketamine infusions in human volunteers: effects on acute thresholds and capsaicin-evoked hyperathia.","volume":"42","author":"Wallace","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"R93-9-20210112","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0304-3959(97)00006-7","article-title":"Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo.","volume":"72","author":"Warncke","year":"1997","journal-title":"Pain"},{"key":"R94-9-20210112","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1526-4637.2007.00290.x","article-title":"The effect of menthol on cold allodynia in patients with neuropathic pain.","volume":"9","author":"Wasner","year":"2008","journal-title":"Pain Med"},{"key":"R95-9-20210112","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/jps.2600810906","article-title":"Lecithin organogel as matrix for transdermal transport of drugs.","volume":"81","author":"Willimann","year":"1992","journal-title":"J Pharm Sci"},{"key":"R96-9-20210112","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF03011718","article-title":"Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain.","volume":"43","author":"Yang","year":"1996","journal-title":"Can J Anaesth"},{"key":"R97-9-20210112","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/AJP.0b013e318175929e","article-title":"Topical fentanyl in a randomized, double-blind study in patients with corneal damage.","volume":"24","author":"Zollner","year":"2008","journal-title":"Clin J Pain"}],"container-title":["Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006396-200911000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:05:45Z","timestamp":1786039545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006396-200911000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1016\/j.pain.2009.05.017","relation":{},"ISSN":["0304-3959"],"issn-type":[{"value":"0304-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}